Literature DB >> 21653307

A randomized noninferiority trial of standard versus enhanced risk reduction and adherence counseling for individuals receiving post-exposure prophylaxis following sexual exposures to HIV.

Michelle E Roland1, Torsten B Neilands, Melissa R Krone, Thomas J Coates, Karena Franses, Margaret A Chesney, James S Kahn, Jeffrey N Martin.   

Abstract

BACKGROUND: The National HIV/AIDS Strategy proposes to scale-up post-exposure prophylaxis (PEP). Intensive risk reduction and adherence counseling appear to be effective but are resource intensive. Identifying simpler interventions that maximize the HIV prevention potential of PEP is critical.
METHODS: A randomized noninferiority study comparing 2 (standard) or 5 (enhanced) risk reduction counseling sessions was performed. Adherence counseling was provided in the enhanced arm. We measured changes in unprotected sexual intercourse acts at 12 months, compared with baseline; HIV acquisition; and PEP adherence. Outcomes were stratified by degree of baseline risk.
RESULTS: We enrolled 457 individuals reporting unprotected intercourse within 72 h with an HIV-infected or at-risk partner. Participants were 96% male and 71% white. There were 1.8 and 2.3 fewer unprotected sex acts in the standard and enhanced groups. The maximum potential risk difference, reflected by the upper bound of the 95% confidence interval, was 3.9 acts. The difference in the riskier subset may have been as many as 19.6 acts. The incidence of HIV seroconversion was 2.9% and 2.6% among persons randomized to standard and enhanced counseling, respectively, with a maximum potential difference of 3.4%. The absolute and maximal HIV seroconversion incidence was 9.9% and 20.4% greater in the riskier group randomized to standard, compared with enhanced, counseling. Adherence outcomes were similar, with noninferiority in the lower risk group and concerning differences among the higher-risk group.
CONCLUSIONS: Risk assessment is critical at PEP initiation. Standard counseling is only noninferior for individuals with lower baseline risk; thus, enhanced counseling should be targeted to individuals at higher risk.
© The Author 2011. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21653307      PMCID: PMC3110285          DOI: 10.1093/cid/cir333

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  29 in total

1.  Comparison of two HIV postexposure prophylaxis regimens among men who have sex with men in Amsterdam: adverse effects do not influence compliance.

Authors:  Gerard J B Sonder; Jan M Prins; Rosa M Regez; Kees Brinkman; Jan-Willem Mulder; Jan Veenstra; Frans A P Claessen; Anneke van den Hoek
Journal:  Sex Transm Dis       Date:  2010-11       Impact factor: 2.830

2.  The Danish PEP registry: experience with the use of postexposure prophylaxis (PEP) following sexual exposure to HIV from 1998 to 2006.

Authors:  Suzanne Lunding; Terese L Katzenstein; Gitte Kronborg; Jens A Lindberg; Janne Jensen; Henrik I Nielsen; Court Pedersen; Louise B Jørgensen
Journal:  Sex Transm Dis       Date:  2010-01       Impact factor: 2.830

Review 3.  Clinical practice. Postexposure prophylaxis for HIV infection.

Authors:  Raphael J Landovitz; Judith S Currier
Journal:  N Engl J Med       Date:  2009-10-29       Impact factor: 91.245

4.  Is offering post-exposure prevention for sexual exposures to HIV related to sexual risk behavior in gay men?

Authors:  C R Waldo; R D Stall; T J Coates
Journal:  AIDS       Date:  2000-05-26       Impact factor: 4.177

5.  Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: the San Francisco PEP Study.

Authors:  J O Kahn; J N Martin; M E Roland; J D Bamberger; M Chesney; D Chambers; K Franses; T J Coates; M H Katz
Journal:  J Infect Dis       Date:  2001-02-01       Impact factor: 5.226

6.  Use of postexposure prophylaxis against HIV infection following sexual exposure does not lead to increases in high-risk behavior.

Authors:  Jeffrey N Martin; Michelle E Roland; Torsten B Neilands; Melissa R Krone; Joshua D Bamberger; Robert P Kohn; Margaret A Chesney; Karena Franses; James O Kahn; Thomas J Coates; Mitchell H Katz
Journal:  AIDS       Date:  2004-03-26       Impact factor: 4.177

7.  Availability of HIV postexposure prophylaxis services in Los Angeles County.

Authors:  Raphael J Landovitz; Kory B Combs; Judith S Currier
Journal:  Clin Infect Dis       Date:  2009-06-01       Impact factor: 9.079

8.  Cost-effectiveness of postexposure prophylaxis after sexual or injection-drug exposure to human immunodeficiency virus.

Authors:  Steven D Pinkerton; Jeffrey N Martin; Michelle E Roland; Mitchell H Katz; Thomas J Coates; James O Kahn
Journal:  Arch Intern Med       Date:  2004-01-12

9.  Behavioral impact, acceptability, and HIV incidence among homosexual men with access to postexposure chemoprophylaxis for HIV.

Authors:  Mauro Schechter; Regina F do Lago; Aaron B Mendelsohn; Ronaldo I Moreira; Lawrence H Moulton; Lee H Harrison
Journal:  J Acquir Immune Defic Syndr       Date:  2004-04-15       Impact factor: 3.731

10.  Coping effectiveness training for men living with HIV: results from a randomized clinical trial testing a group-based intervention.

Authors:  Margaret A Chesney; Donald B Chambers; Jonelle M Taylor; Lisa M Johnson; Susan Folkman
Journal:  Psychosom Med       Date:  2003 Nov-Dec       Impact factor: 4.312

View more
  15 in total

1.  The Transition From Postexposure Prophylaxis to Preexposure Prophylaxis: An Emerging Opportunity for Biobehavioral HIV Prevention.

Authors:  Sachin Jain; Douglas S Krakower; Kenneth H Mayer
Journal:  Clin Infect Dis       Date:  2015-06-01       Impact factor: 9.079

2.  Optimizing adherence to preexposure and postexposure prophylaxis: the need for an integrated biobehavioral approach.

Authors:  Aaron J Blashill; Peter P Ehlinger; Kenneth H Mayer; Steven A Safren
Journal:  Clin Infect Dis       Date:  2015-06-01       Impact factor: 9.079

3.  High Levels of Concomitant Behavioral Health Disorders Among Patients Presenting for HIV Non-occupational Post-exposure Prophylaxis at a Boston Community Health Center Between 1997 and 2013.

Authors:  Sachin Jain; Catherine E Oldenburg; Matthew J Mimiaga; Kenneth H Mayer
Journal:  AIDS Behav       Date:  2016-07

4.  Longitudinal trends in HIV nonoccupational postexposure prophylaxis use at a Boston community health center between 1997 and 2013.

Authors:  Sachin Jain; Catherine E Oldenburg; Matthew J Mimiaga; Kenneth H Mayer
Journal:  J Acquir Immune Defic Syndr       Date:  2015-01-01       Impact factor: 3.731

Review 5.  Antiretrovirals for primary HIV prevention: the current status of pre- and post-exposure prophylaxis.

Authors:  Douglas S Krakower; Sachin Jain; Kenneth H Mayer
Journal:  Curr HIV/AIDS Rep       Date:  2015-03       Impact factor: 5.071

Review 6.  Helping our patients take HIV pre-exposure prophylaxis (PrEP): a systematic review of adherence interventions.

Authors:  J L Marcus; T Buisker; T Horvath; K R Amico; J D Fuchs; S P Buchbinder; R M Grant; A Y Liu
Journal:  HIV Med       Date:  2014-02-24       Impact factor: 3.180

7.  Opportunities for HIV combination prevention to reduce racial and ethnic health disparities.

Authors:  Cynthia I Grossman; David W Purcell; Mary Jane Rotheram-Borus; Rosemary Veniegas
Journal:  Am Psychol       Date:  2013 May-Jun

8.  Availability of HIV postexposure prophylaxis services in Los Angeles County.

Authors:  Raphael J Landovitz; Kory B Combs; Judith S Currier
Journal:  Clin Infect Dis       Date:  2009-06-01       Impact factor: 9.079

Review 9.  Adherence to post-exposure prophylaxis for non-forcible sexual exposure to HIV: a systematic review and meta-analysis.

Authors:  Catherine E Oldenburg; Till Bärnighausen; Guy Harling; Matthew J Mimiaga; Kenneth H Mayer
Journal:  AIDS Behav       Date:  2014-02

10.  Integrated strategies for combination HIV prevention: principles and examples for men who have sex with men in the Americas and heterosexual African populations.

Authors:  Connie Celum; Jared M Baeten; James P Hughes; Ruanne Barnabas; Albert Liu; Heidi Van Rooyen; Susan Buchbinder
Journal:  J Acquir Immune Defic Syndr       Date:  2013-07       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.